CoChat

The Effects of Once-Weekly Dulaglutide and Insulin Glargine on Glucose Fluctuation in Poorly Oral-Antidiabetic Controlled Patients with Type 2 Diabetes Mellitus

Open access
Wang, Jie, Li, Hui-qin, Xu, Xiao-hua, Kong, Xiao-cen, Sun, Rui, Jing, Ting, Ye, Lei, Su, Xiao-fei, Ma, Jian-hua · 2019 · BioMed Research International
Cited by 23

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Aim. To compare the effects of once-weekly Dulaglutide with once-daily glargine in poorly oral-antidiabetic controlled patients with type 2 diabetes mellitus (T2DM). Method. A total of 25 patients with T2DM admitted into Department of Endocrinology from December 2012 to August 2013 were randomly assigned into two groups: Dulaglutide group (n=16) and glargine group (n=9). All patients received either Dulaglutide or glargine treatments for 52 weeks. Continuous glucose monitoring systems (CGMS) were applied to them for two 72 h periods at before and after the treatment each. Patient general clinical data were collected and analyzed. Result. Fast blood glucose (FBG) of the glargine group declined more significantly than the Dulaglutide group after treatment (p<0.05). The mean blood glucose (MBG), standard deviation of blood glucose (SDBG), mean amplitude of glycemic excursion (MAGE) within a day, the largest amplitude of glycemic excursion (LAGE), M-value, absolute means of daily difference (MODD) of glycemic excursion, the percentage of time (≤2.8 mmol/L, ≤3.9 mmol/L, ≥10.0 mmol/L, ≥13.9 mmol/L, 3.9–7.8 mmol/L, and 9–10.0 mmol/L), maximum glycemic value, and minimum glycemic value were similar between the two groups (p>0.05). The incidence of hypoglycemia was also similar between the two groups (p>0.05). Though serum levels of TNF-α, IL-6, and 8-PGF2 α all decreased, significant reduction was found in TNF-α and 8-PGF2 α. TNF-α was only significantly reduced in the Dulaglutide group, while 8-PGF2 α was seen in both groups. Conclusion. For T2DM patients with poorly controlled oral antidiabetic drugs, once-weekly Dulaglutide not only has the same effect on glucose fluctuation as once-daily glargine but also significantly reduced TNF-α and 8-PGF2 α after a 52 week treatment protocol. This trial is registered with ClinicalTrials.gov NCT01648582.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2019/2682657

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 16

  1. 10.1016/j.diabres.2017.03.024 · DOI · Paper page
  2. 10.1016/j.arcmed.2005.01.003 · DOI · Paper page
  3. 2011, Pharmaceutical Journal, 1
  4. 10.1053/j.gastro.2007.03.054 · DOI · Paper page
  5. 10.1002/dmrr.1080 · DOI · Paper page
  6. 10.1111/j.1463-1326.2011.01365.x · DOI · Paper page
  7. 10.1016/j.diabres.2007.08.007 · DOI
  8. 10.1016/S0140-6736(15)60936-9 · DOI · Paper page
  9. 10.1111/dom.12705 · DOI · Paper page
  10. 10.2337/db12-1610 · DOI · Paper page
  11. 10.2337/dc16-1738 · DOI · Paper page
  12. 10.2337/dc13-2759 · DOI · Paper page
  13. 10.1111/dom.12540 · DOI · Paper page
  14. 10.2337/dc14-0001 · DOI · Paper page
  15. 10.2337/dc14-0876 · DOI · Paper page
  16. 10.1007/s00125-009-1556-8 · DOI · Paper page

Cited by

See all 23

Metadata

Authors
Wang, J., Li, H.-Q., Xu, X.-H., Kong, X.-C., Sun, R., Jing, T., Ye, L., Su, X.-F., & Ma, J.-H.
Venue
BioMed Research International
Publisher
Wiley
Published
2019-12-25
Volume
2019
Pages
1-8
ISSN
  • 1110-7243 (ISSN-L)
  • 2314-6133
  • 2314-6141
OpenAlex
W2997768671
Cited by
23
References
8
FWCI
0.86
Type
journal article
Language
en
Open access
hybrid
Funders
Government of Jiangsu Province (BL2014010)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Effects of Once-Weekly Dulaglutide and Insulin Glargine on Glucose Fluctuation in Poorly Oral-Antidiabetic Controlled Patients with Type 2 Diabetes Mellitus. https://app.cochat.ai/papers/10.1155/2019/2682657
The paper
Wang, J., Li, H.-Q., Xu, X.-H., Kong, X.-C., Sun, R., Jing, T., Ye, L., Su, X.-F., & Ma, J.-H. (2019). The Effects of Once-Weekly Dulaglutide and Insulin Glargine on Glucose Fluctuation in Poorly Oral-Antidiabetic Controlled Patients with Type 2 Diabetes Mellitus. BioMed Research International. https://doi.org/10.1155/2019/2682657

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.